Results 61 to 70 of about 5,617 (179)

Refractory Chronic Pleurisy Caused by Helicobacter equorum-Like Bacterium in a Patient with X-Linked Agammaglobulinemia [PDF]

, 2011
We describe a 35-year-old man with X-linked agammaglobulinemia who had refractory chronic pleurisy caused by a Helicobacter equorum- like bacterium. Broad-range bacterial PCR targeting the 16S and 23S rRNA genes and in
Naomi Kondo, Kiyofumi Ohkusu, Zenichiro Kato, Michinori Funato, Hideo Kaneko, Kazuo Kubota, Hideo Sasai, Hidenori Ohnishi, Toshiyuki Fukao   +8 more
core   +1 more source

Factors Affecting Immune Reconstitution Post‐Allogeneic HSCT in Children: The Case for an Individualized Approach to Vaccination

European Journal of Haematology, Volume 116, Issue 4, Page 336-349, April 2026.
ABSTRACT Allogeneic hematopoietic stem cell transplantation (HSCT) is increasingly used to treat malignant and non‐malignant diseases. Following allogeneic HSCT, patients are particularly vulnerable to vaccine‐preventable diseases (VPD) because conditioning depletes immune cells, including memory cells.
Hélène Buvelot, Frederic Baleydier, Laure Pittet, Geraldine Blanchard‐Rohner   +3 more
wiley   +1 more source

Viral Immunity in Immunoglobulin Products: Global Immunity Debt and Autoimmunity in the Postpandemic Era

European Journal of Immunology, Volume 56, Issue 3, March 2026.
Immunoglobulin products derived from pooled global plasma reflect population‐level antiviral immunity. Analysis of batches from 2017 to 2023 reveals pandemic‐driven shifts in viral antibody profiles and a concurrent rise in autoantibodies, notably against TRIM21/Ro52, highlighting links between SARS‐CoV‐2, immunity debt, and autoimmunity.
Hannes Lindahl, Katy Shaw‐Saliba, H. Benjamin Larman, C. I. Edvard Smith, Peter Bergman   +4 more
wiley   +1 more source

Clinical Spectrum of Cutaneous, Ocular, and Hair Manifestations in Patients With Inborn Errors of Immunity: Insights From a Single Center in Turkey

Immunity, Inflammation and Disease, Volume 14, Issue 2, February 2026.
ABSTRACT Background Inborn errors of immunity (IEI), previously referred to as primary immunodeficiencies, are a heterogeneous group of genetic disorders affecting immune development and function. While once considered rare, IEIs are increasingly recognized, particularly in regions with high consanguinity rates.
Burcu Cil Yılmaz, Sibel Kaplan Sarikavak, Sezin Naiboglu, Gulsah Kalay, Erkan Cakmak, Ozge Turkyilmaz Ucar, Selami Ulas, Nermin Kapci, Pinar Gokmirza, Cigdem Aydogmus   +9 more
wiley   +1 more source

Neutropenia Associated with X-Linked Agammaglobulinemia

Iranian Journal of Allergy, Asthma and Immunology, 2009
X-linked Agammaglobulinemia (XLA) is a hereditary immunodeficiency, characterized by an early onset of recurrent bacterial infections, hypogammaglobulinemia and markedly reduced B lymphocytes number.
Aghamohammadi Asghar, Cheraghi Taher , Rezaei Nima, Kanegane Hirokazu, Abdollahzede Sina, Talaei-Khoei Mojtaba, Heidari Golnaz , Zandieh Fariborz, Moin Mostafa, Miyawaki Toshio   +9 more
doaj  

Pseudomonas aeruginosa sepsis presenting as oral ecthyma gangrenosum in identical twins with Bruton tyrosine kinase gene mutation: Two case reports and review of the literature

Journal of Microbiology, Immunology and Infection, 2020
X-linked agammaglobulinemia (XLA) is a primary immunodeficiency disease. We reported two 7-month-old identical male twins with Pseudomonas aeruginosa sepsis who initially manifested as oral ecthyma gangrenosum and were finally diagnosed to have XLA.
Sheng-Chieh Lin, Bor-Luen Chiang, Yuarn-Jang Lee, Ya-Ting Chang, Shiuh-Bin Fang   +4 more
doaj   +1 more source

Six‐Year Trends in Real‐World Data Use for Post‐Marketing Surveillance of New Medical Products in Japan

Clinical and Translational Science, Volume 19, Issue 2, February 2026.
ABSTRACT The Ministerial Ordinance on Good Post‐Marketing Study Practice for Drugs was amended by the Ministry of Health, Labour and Welfare (MHLW) in 2018 to clearly define post‐marketing database studies (DBS) as a measure of pharmacovigilance activities for approved medical products in Japan.
Suguru Okami, Kako Shimotsumagari, Yasunari Sadatsuki   +2 more
wiley   +1 more source

Comparison of oral microflora in selective IgA deficiency and X linked agammaglobulinemia cases with control group [PDF]

, 2013
Aim: X linked agammaglobulinemia (XLA) and selective IgA deficiency are predominantly antibody deficiency syndromes. Recurrent sinopulmonary infections are common problems observed in both diseases.
Necla Akcakaya, Haluk Cokugras, Topcuoglu, Nursen, Yildiz Camcioglu, Kulekci, Guen, Akcakaya, Necla, Camcioglu, Yildiz, Ayca Aslan Kiykim, ÇOKUĞRAŞ, HALUK CEZMİ, Guven Kulekci, Nursen Topcuoglu, KIYKIM, AYÇA   +11 more
core   +1 more source

Molecular characterization of Agammaglobulinemia, X-linked 1: A case-series from Iran

Human Pathology Reports
X-linked agammaglobulinemia (XLA) is among the most frequent primary immunodeficiencies in childhood. This disorder is caused by a disruption in B cell development resulted from mutations in Bruton’s tyrosine kinase (BTK) gene.
Sheyda Khalilian, Mohadeseh Fathi, Nima Parvaneh, Soheila Alyasin, Abbas Fayezi, Taher Cheraghi, Maziyar Rahimi, Soudeh Ghafouri-Fard, Mohammad Miryounesi, Mohammad Shahrooei   +9 more
doaj   +1 more source

BTKbase: the mutation database for X-linked agammaglobulinemia [PDF]

Human Mutation, 2006
X-linked agammaglobulinemia (XLA) is a hereditary immunodeficiency caused by mutations in the gene encoding Bruton tyrosine kinase (BTK). XLA patients have a decreased number of mature B cells and a lack of all immunoglobulin isotypes, resulting in susceptibility to severe bacterial infections. XLA-causing mutations are collected in a mutation database
Jouni, Väliaho, C I Edvard, Smith, Mauno, Vihinen   +2 more
openaire   +2 more sources